Effect of apple vinegar on lipid profile, insulin resistance and homocysteine in type 2 diabetic patients with dyslipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013070710826N5

Enrollment

Registered

2013-07-17

Start date

2013-09-16

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes type 2 with dislipidemia.

Interventions

Intervention 1: The intervention group will asked to use 20 mili liter of apple vinegar daily(2 tablespoons of apple vinegar solved in a glass of water 30 minutes before the launch and also do it for

No intervention will be done in the Control group

The intervention group will asked to use 20 mili liter of apple vinegar daily(2 tablespoons of apple vinegar solved in a glass of water 30 minutes before the launch and also do it for dinner) for 3 mo

Eligibility

Sex/Gender

All

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Type 2 diabetic patients with dyslipidemia; age between 25-60 years old; do not inject insulin; not pregnant or lactating; do not have any other diseases like gastrointestinal, liver, renal or thyroid disease; individuals who arent under special diet and dont participate in another intervention. Exclusion criteria: appearance of disease during the intervention; change in drugs during the intervention; using less than 80 percent of determined apple vinegar during the intervention.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum levels of homocystein. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Lipid profiles(Cholestrol,TG,HDL,LDL). Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Insulin hormon levels. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Fasting blood sugar. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Blood pressure. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: sphygmomanometer.;Weight. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: digital scale.;Height. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: meter.	—

Measure

Time frame

Serum levels of homocystein. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Lipid profiles(Cholestrol,TG,HDL,LDL). Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Insulin hormon levels. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Fasting blood sugar. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: blood biochemical tests.;Blood pressure. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: sphygmomanometer.;Weight. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: digital scale.;Height. Timepoint: before the intervention and 3 month after the intervention. Method of measurement: meter.

—

Secondary

Measure	Time frame
BMI. Timepoint: Before and after 3 month of intervention. Method of measurement: scale, meter.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026